The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection-Reference-Cited by-同舟云学术

The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection

Published:2012-01-03 Issue:1 Volume:122 Page:303-314
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Lin Philana Ling,Dietrich Jes,Tan Esterlina,Abalos Rodolfo M.,Burgos Jasmin,Bigbee Carolyn,Bigbee Matthew,Milk Leslie,Gideon Hannah P.,Rodgers Mark,Cochran Catherine,Guinn Kristi M.,Sherman David R.,Klein Edwin,Janssen Christopher,Flynn JoAnne L.,Andersen Peter

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference43 articles.

1. Kaufmann SH, Andersen P.Immune Intervention Strategies against Tuberculosis in the Immune Response to Infection. Washington, D.C., USA. ASM press. In press.

2. Preclinical testing of new vaccines for tuberculosis: A comprehensive review

3. The Growing Burden of Tuberculosis

4. Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy

5. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis.

Cited by 219 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-clinical characterisation: Which animal model is best for infection?;Nanotechnology Tools for Infection Control;2025

2. Immunoproteomic discovery of Mycobacterium bovis antigens, including the surface lipoprotein Mpt83 as a T cell antigen useful for vaccine development;Vaccine;2024-10

3. A multistage protein subunit vaccine as BCG-booster confers protection against Mycobacterium tuberculosis infection in murine models;International Immunopharmacology;2024-09

4. An intranasal nanoparticle vaccine elicits protective immunity against Mycobacterium tuberculosis;Vaccine;2024-09

5. Trends in Viral Vector-Based Vaccines for Tuberculosis: A Patent Review (2010–2023);Vaccines;2024-08-02